chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a pharmacist concerning a patient of unknown age and gender. The patient's medical history, drug reactions/allergies,concurrent conditions and concomitant medications were not provided. On an unknown date, the patient was inadvertently vaccinated a dose of PREVNAR 13 lot # S35324 with expiration date August 2018 (dose, strength, frequency, route of administration and anatomical location were not provided), for prophylaxis instead of the intended dose of PNEUMOVAX 23 (dose, strength, frequency, route of administration, anatomical location, lot# and expiraiton date were not provided), for prophylaxis. No adverse effects were reported.
This spontaneous report as received from a physician via a company representative refers to a 17 year old female patient with Crohn's disease. On 28-JAN-2014, the patient was vaccinated with the first dose of RECOMBIVAX HB. Dose 2 of RECOMBIVAX HB was administered at the end of February 2014, and the third dose on 30-APR-2014. The patient did not receive any other vaccines at the same time as RECOMBIVAX HB. The physician reported that the third dos of RECOMBIVAX HB was administered too soon (on 30-APR-2014). There were no serious side effects. An outcome was not reported. Additional information has been requested.
Patient was administered an extra dose of a vaccine (Dtap) instead of another vaccine that was suppose to be given (Hep B), Patient was in good standings after vaccine was given and when patient left clinic and was okay. No reports of any reactions or symptoms to vaccine after it was administered, Patient was immediately called back and informed about extra dose of vaccine that was given and  to come back to the clinic to receive correct vaccine (Hep B)
Hospitalized 10/27/2021; COVID-19 positive 10/27/2021; fully vaccinated  BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider at Discharge: MD Admission Date: 10/27/2021 Discharge Date: 10/31/2021 DETAILS OF HOSPITAL STAY: HOSPITAL COURSE: Patient is a 79 y.o. male, with a past medical history of CAD, NSTEMI, and LVH who admitted to Hospital on 10/27/2021 with COVID-19 pneumonia with cough, chills and shortness of breath.At the ER, he was hypoxic at 88% on room air and developed a new onset fever. He had a positive COVID-19 screen at the ER which is newly diagnosed.  He was put on 3L O2 on nasal cannula and given as needed tylenol for his fever as high as 39.4c.  On physical exam he had unremarkable findings. Lab showed COVID-19 positive, a increase in D-dimer, anemia, and a elevated CRP. His glucose went up to 469 and was given lantus and lispro. On 10/27 he was given remdesivir and decadron. Xray showed mild increase in pulmonary vascular distention. He was admitted to the hospital for symptom management. He gradually weaned off of his nasal canula and had gradually reduced his symptoms, he was given his remdesivir and decadron throughout. Throughout the hospitalization,blood sugars would fluctuate between 150-255 and was given insulin medication. Been afebrile since the morning of 10/29 and did not require a nasal canula since 10/30. Labs showed a steady decrease in his CRP level to 53.8 and D-dimer level to normal limits.  On discharge he had no complaints of any symptoms. He was walking around and breathing on room air.  He completed his 5/5 remdesivir treatment and is on day 5/10 of his decadron.
Sick; This is a spontaneous report received from a non-contactable consumer, Program ID: (RA).  An elderly female patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "recovered", described as "Sick".  Additional Information: The patient got Pfizer COVID-19 vaccine one day and was sick for a week. The patient's friend considered that the event was caused by the suspect product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Swollen lymph nodes in neck, under jaw near adam's apple, midline; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Swollen lymph nodes in neck, under jaw near adam's apple, midline) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939676) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included VITAMINS NOS for an unknown indication.    On 03-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Aug-2021, the patient experienced LYMPHADENOPATHY (Swollen lymph nodes in neck, under jaw near adam's apple, midline). The patient was treated with PARACETAMOL (TYLENOL) for Swollen lymph nodes, at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) for Swollen lymph nodes, at an unspecified dose and frequency. At the time of the report, LYMPHADENOPATHY (Swollen lymph nodes in neck, under jaw near adam's apple, midline) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Immediately after HPV immz, the patient said, "Is it normal to feel dizzy like this", then she lost her consciousness. She fell from the exam table, which is 33 inches high, onto the laminate floor with her head first and her neck flexed. She appeared pale. She was laid supine on the floor with her legs raised. Duration of LOC was about 30 seconds. Her BP was 60 bpm, SpO2 was 98% during LOC. Called 911. Alcyone woke up, asked 'what happened?', answered a few questions correctly(name, etc), repeated her mom's prayer without slur. EMT arrived, checked her status, immobilized her neck and spine and took her to ED to evaluate the head and neck injury from concussion.
Began feeling mildly nauseous shortly after the shot. The nausea lasted for most of the day. Around noon felt some pain in my "stomach." By about 3pm I started to have a lot of pain in my abdomen. By 5pm the pain was severe all around my abdomen to the point I was barely able to stand up. Sitting provided some relief. Laying flat for a while caused the pain to subside but every time I stood up or sat up the pain returned within a few minutes. The pain can only be described as cramping, which lasted about 2 days. My abdomen muscles remained sore and sensitive for a few more days following.
31 yo healthy female who received SPV and anthrax #2 vaccine 11 days ago with a dermatitis (onset day 10) to arms, legs, buttocks, and a few lesions to chest and abdomen. The lesions are fine papular, very pruritic, and non-painful. She is feeling well. Lesions are discrete, no vesicles or pustules or bruising. The lesions do not come and go and have improved since onset. No lesions to her palms or soles. ROS otherwise unremarkable. No history of eczema, atopic dermatitis, asthma or allergic rhinitis. Photos were sent and reviewed. The dermatitis is not consistent with a concerning adverse event such as generalized vaccinia, and is most are suggestive of an immune mediated dermatitis particularly nonviral pustulosis, and the onset is within the typical timeframe, and she has no systemic symptoms and feels well.
I had severe headaches. I deal with that until I could not stand it. I lost feeling in my left side.  I went to the ER. They had done a MRI, CT scan and a spinal tap, which showed that I had extra spinal fluid. I had idiopathic intracranial hypertension that I was leaking spinal fluid.  I have seen a neurologist.  I am going to be on medicine for the rest of my life from this.
Period started  the week got the vaccine. It normally lasts 5-7 days, but it hasn't stopped since.; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731), via an unspecified route of administration in the left arm on 10Apr2021 at 10:30 (at the age of 16-years-old), as a single dose for COVID-19 immunisation. Medical history included seasonal allergies. Concomitant medications included ibuprofen (ADVIL), pseudoephedrine hydrochloride; cetirizine hydrochloride (ZYRTEC D 12HR), fluoxetine (MANUFACTURER UNKNOWN) capsule PO 20mg; all from unknown dates for unspecified indications. On 16Mar2021, the patient received meningococcal vaccine B rfHbpA/fHpB (MEN-B (TRUMENBA) PFS) vaccine in the right arm within four weeks of the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 11Apr2021, the patient experienced period started the week she got the vaccine.It normally lasts 5-7 days but it hasn't stopped since. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event period started the week she got the vaccine, it normally lasts 5-7 days but it hasn't stopped since was not resolved at the time of reporting. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167), via an unspecified route of administration on 01May2021 at 10:30 (at the age of 16-years-old), as a single dose for COVID-19 immunisation.   No follow-up attempts are needed. No further information is expected.
The vaccine was administered one day post expiration date.  The expiration date is dynamic and is not printed on the vial.  J&J has been updating the expiration date and has been extended the date multiple times over the last 6 months.  The company was contacted and they do not recommend a repeat dose.  The patient experienced no adverse reaction.
lower inner arm was very itchy; turned into a hives and then a wheel; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 84-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 06Oct2022 as dose 5 (booster), single (Lot number: GH9693) at the age of 84 years, in arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (Dose: 1, Lot: EK9231), administration date: 22Jan2021, when the patient was 82-year-old, for Covid-19 immunization; BNT162b2 (Dose: 2, Lot: EL9269), administration date: 13Feb2021, when the patient was 82-year-old, for Covid-19 immunization; BNT162b2 (Dose: 3, Lot: FH8028), administration date: 09Nov2021, when the patient was 83-year-old, for Covid-19 immunization; BNT162b2 (Dose: 4, Lot: FJ4991), administration date: 23Jun2022, when the patient was 84-year-old, for Covid-19 immunization. The following information was reported: PRURITUS (non-serious) with onset 2022, outcome "unknown", described as "lower inner arm was very itchy"; URTICARIA (non-serious) with onset 2022, outcome "unknown", described as "turned into a hives and then a wheel".  Additional information: Patient had her injection yesterday and her lower inner arm was very itchy and lasted a short time and turned into a hives and then a wheel a couple of hours later. She had no other symptoms no shortness of breath or anything else and Patient was fine today the wheel has turned into a raised red welt and can be itchy. Caller then proceeds to states that she worked in a hospital for many years and started at an allergy department many years ago. She knows what a hive looks like. But it is usually more than one. This is unusual. There no relevant test. There are no family medical history.Prior to vaccination patient did not receive any other vaccine within 4weeks.It is only one hive and it was on the same arm just seems like it was related to the vaccine. She is just really concerned if it would be worse next time.  No follow-up attempts are possible. No further information is expected.
Flu like symptoms first 2 days: body and headaches, nausea.  Tuesday, Wednesday felt better. Thursday 101.0 fever
Pretty sick after the second shot, too; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced sickness. On an unknown date, the outcome of the sickness was recovered/resolved.   It was unknown if the reporter considered the sickness to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient for himself or herself. The age at vaccination was not reported.  The age group was selected as an adult as per vaccine indication. The reporter stated that, got sick after 1st shot of Shingles vaccine. The reporter had a feeling how he/she was going to feel after his or her 2nd COVID vaccine next week. For the tolerance in 2nd dose refer case US2021AMR069288, reported by same reporter for same patient.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR069288:same reporter
vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine given 6 days post expiry) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 041L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.   This case was linked to MOD-2021-395985 (Patient Link).
Developed Human Metapneumonia virus exactly seven weeks later and had to be hospitalized for three nights. When home with homecare that involved PT, OT, ST, and nursing. Has been unable to work since becoming ill due to fatigue and shortness of breath. Was living independently in his own apartment and working part-time and is now in an assisted living due to illness.
Post Vaccine, patient complained of dizziness. Placed on lying position, VS 140/90, P-89, R- 18, no SOB patient is responsive when name is called, no s/s of allergic reactions. - the facility personnel called the paramedics, report given to EMTs.  Upon arrival of EMS, patient was awake and initially refused to be transported to the hospital, was able to transfer from chair to gurney with assistance. Patient was transported to the nearest ER for further eval.  Unable to obtain second set of V/S as patient was being assessed by the paramedics.
Patient received the immunization. Was escorted to a chair for observation for 15 minutes. After about 10 minutes she said she was feeling faint and put her head down on the counter. We asked her how she was feeling, she said faint and began shaking. Called 911, applied a cold pack to her neck and fanned her.  After about 7 minutes she said she was feeling better. EMS arrived, took her pulse and blood pressure. Asked her pertinent questions, What is your name, what day is it, who is the president?  etc. They determined she was good to go after about 12 minutes
Patient received first dose of Moderna COVID vaccine on 2/28/21, second dose on 3/28/21. Patient presented to reporting hospital 10/13/21 with complaint of SoB, fever, headache, dry cough since 10/9/21. Also notes fatigue, thirst. Admission PCR test administered via NP on 10/13, positive the same day. Patient currently still admitted 10/21, expected/tentative discharge listed as 10/22.
Approximately 5 minutes post vaccine pt notes increased saliva production an diaphoresis.. No oral swelling, no vomiting, no AB pain , no rash , no sob.  Glucose 63.  After po food and fluids, pt at baseline.  Monitored  x60 minutes.  At baseline prior to dc.
Sore upper arm, headache, nauseous, hives, tired, shivering
Starting around 8 hours after injection, low-grade fever (around 100-101 degrees), extreme fatigue, chills, aches and pains all over body. Moderate to severe headache. Slept very poorly the night of the injection, and was mostly incapacitated all following day. Started feeling better late following evening, approximately 36 hours after injection. Feeling mostly back to normal the morning of the second day after injection, with minor lingering headaches.
he is struggling right now; Chills; Sweat/legs were sweating; low grade fever; This is a follow-up spontaneous report from a contactable consumer (reported for husband). A 65-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number: EW0170 and expiration dates were not reported), via an unspecified route of administration on 30Apr2021 as second dose, single for COVID-19 immunization. Medical history included surgery on his foot. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number and expiration dates were not reported), via an unspecified route of administration on 09Apr2021 as single dose for COVID-19 immunization and experienced no adverse event. The patient's concomitant medications were not reported. On an unknown date, the patient was struggling right now. In May2021, the patient experienced chills, sweat/legs were sweating and low grade fever. The outcome of the events was unknown. The Consumer reported that patient was administered with the second dose on 30Apr2021 and felt well after but a couple of days after patient started having chills, fever and sweating. The fever and sweating had persisted since only in the morning and it goes away around 10:00 AM. It was reported that from 2 weeks since patient received the 2nd dose, every day from 6am to 10am patient gets profuse sweating (legs were sweating) and low grade fever and chills. It was reported that due to the sweating patient wets its clothes. The 2 different Physicians recommended the use of Acetaminophen for the management of these symptoms. It was reported that one of patient co-workers got the Moderna vaccine and its affected was hearing. The outcome of the event was unknown.  Follow-up#01(11May2021): This is a follow-up spontaneous report from a contactable consumer. This consumer reported for a patient (reporters husband) that: patient events details were updated.  Follow-up(12May2021 and 13May2021):This is a follow-up spontaneous report from a contactable consumer. This consumer reported for a patient (reporters husband) that: no new information was updated.  No follow-up attempts are needed. No further information is expected
Started to lose voice and clearing throat- took benedryl as suggested , stayed an extra hour for observation, left on my own. Noticed face was swollen  and red after showering- took photo. Cough and clearing throat like when I eat something I?m allergic to. Took another benedryl four hours later as well as Tylenol for headache. Ate dinner went back to sleep notice arm hurts a bit. Next morning 9 am face no longer swollen but arm hurting to the slightest touch. 4:30 pm still resting arm very painful . Headache and facial swelling under control. At no time did I have trouble breathing, slight itching
Rash on lips; Rash on left eye lids; Rash on face and nose; Chills; High Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of CHEILITIS (Rash on lips), EYELID RASH (Rash on left eye lids), CHILLS (Chills), PYREXIA (High Fever) and HEADACHE (Headache) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No concomitant medications were reported.  The patient's past medical history included Herpes simplex.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced CHILLS (Chills), PYREXIA (High Fever) and HEADACHE (Headache). On 07-Feb-2021, the patient experienced CHEILITIS (Rash on lips), EYELID RASH (Rash on left eye lids) and RASH (Rash on face and nose). At the time of the report, CHEILITIS (Rash on lips), EYELID RASH (Rash on left eye lids), CHILLS (Chills), PYREXIA (High Fever), HEADACHE (Headache) and RASH (Rash on face and nose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication use was provided by the reporter.  No treatment of events was reported.Patient was vaccinated 6FEB2021. That same day, had chills, high fever and a headache. The next day 7FEB2021, had a rash on her face, nose , lip, and left eye. Has a history of herpes simplex.
Case number PHEH2013US020838 is an initial spontaneous report received from a nurse on 02 OCT 2013. This report refers to a patient of unknown age and gender. The patient was given only the Men A component of MENVEO (batch number: unknown) intramuscularly on an unknown date. MenA was reconstituted with water instead of MenCYW-135. No adverse event was reported following this administration error (wrong solution used in drug reconstitution).
1st dose received just before Covid/not able to get the second yet / had the second last Tuesday; painful side effect with pain; low grade fever; feeling like a wet noodle; This case was reported by a consumer and described the occurrence of pain in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included ophthalmic herpes zoster (very mild case around left eye years ago) and shingles (Family History) (great granddaughter had it when she was 19, mother in law had every year and so did sister in law). Previously administered products included Shingles vaccine (as original shingles vaccination, received on an unknown date) and Shingles vaccine (1st dose of new vaccine received in last year, just before COVID).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown.  Additional details were reported as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The age group was not reported but was selected as an adult as per vaccine indication. The patient had the original shingles vaccination when it (unspecified) came out. Till the time of reporting, the patient was not able to get the 2nd of the new vaccine. The follow-up would not possible as no contact details were available.   Follow-up information received from consumer on 16th August 2021: The patient had 1st dose of new Shingles vaccine just before Covid hit. The patient received the 2nd dose of new Shingles vaccine on last Tuesday before reporting date due to Covid hit. One day after the vaccination with 2nd dose, the patient had painful side effect with pain, low grade fever and felt like a wet noodle. The patient was fine on 2nd day of vaccination.